Literature DB >> 10760303

A genetic model defines the importance of the atrial natriuretic peptide receptor (guanylyl cyclase-A) in the regulation of kidney function.

S K Dubois1, I Kishimoto, T O Lillis, D L Garbers.   

Abstract

Disruption of the atrial natriuretic peptide (ANP) receptor [guanylyl cyclase-A (GC-A)] gene yields mice with a salt-resistant form of hypertension, raising fundamental questions on the role of ANP in acute regulation of the kidney. Here, we show that water intake, food consumption, stool weight, urine volume, and sodium excretion are not significantly different between wild-type and GC-A null mice on standard rodent chow (0.7% NaCl) or a high-salt diet (8% NaCl). In conscious mice with an indwelling catheter, the infusion of a physiological saline solution containing 4% BSA resulted in a marked natriuresis/diuresis in wild-type mice but no response in GC-A null animals. When physiological saline was given by gavage, however, the kidney response of wild-type and null mice was equivalent, raising the possibility that the gastrointestinal tract can directly regulate kidney function. However, administration of 0.9% saline through an intraperitoneal route also resulted in equal kidney responses in wild-type and null mice. When 0.9% NaCl lacking protein was infused i.v., wild-type and null mice both responded at the kidney level. Thus, GC-A appears dispensable for regulation of sodium/water excretion in response to changes in dietary sodium concentration, but likely becomes critical in volume expansions where the isooncotic pressure remains constant, such as head-out immersion or the initial and correctable stages of congestive heart failure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760303      PMCID: PMC18248          DOI: 10.1073/pnas.97.8.4369

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Structure and activity of OK-GC: a kidney receptor guanylate cyclase activated by guanylin peptides.

Authors:  R M London; S L Eber; S S Visweswariah; W J Krause; L R Forte
Journal:  Am J Physiol       Date:  1999-06

2.  Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.

Authors:  T Nishikimi; F Yoshihara; A Morimoto; K Ishikawa; T Ishimitsu; Y Saito; K Kangawa; H Matsuo; T Omae; H Matsuoka
Journal:  Hypertension       Date:  1996-07       Impact factor: 10.190

3.  Atrial natriuretic peptide in the subfornical organ reduces drinking induced by angiotensin or in response to water deprivation.

Authors:  K J Ehrlich; D A Fitts
Journal:  Behav Neurosci       Date:  1990-04       Impact factor: 1.912

4.  Effect of increased peritubule protein concentration on proximal tubule reabsorption in the presence and absence of extracellular volume expansion.

Authors:  C E Ott; J A Haas; J L Cuche; F G Knox
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

5.  Evidence for a splanchnic sodium input monitor regulating renal sodium excretion in man. Lack of dependence upon aldosterone.

Authors:  R M Carey
Journal:  Circ Res       Date:  1978-07       Impact factor: 17.367

6.  The influence of age on renal function and renin and aldosterone responses to sodium-volume expansion and contraction in normotensive and mildly hypertensive humans.

Authors:  F C Luft; N S Fineberg; M H Weinberger
Journal:  Am J Hypertens       Date:  1992-08       Impact factor: 2.689

7.  Atrial natriuretic factor inhibits dehydration- and angiotensin II-induced water intake in the conscious, unrestrained rat.

Authors:  J Antunes-Rodrigues; S M McCann; L C Rogers; W K Samson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  Red-cell sodium-lithium countertransport and fractional excretion of lithium in normal and hypertensive humans.

Authors:  M H Weinberger; J B Smith; N S Fineberg; F C Luft
Journal:  Hypertension       Date:  1989-03       Impact factor: 10.190

9.  Blunted natriuresis to atrial natriuretic peptide in chronic sodium-retaining disorders.

Authors:  J P Koepke; G F DiBona
Journal:  Am J Physiol       Date:  1987-05

10.  Role of endogenous atrial natriuretic peptide in congestive heart failure.

Authors:  M Awazu; T Imada; V Kon; T Inagami; I Ichikawa
Journal:  Am J Physiol       Date:  1989-09
View more
  11 in total

1.  Natriuretic peptide receptors and the heart.

Authors:  L King; M R Wilkins
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

2.  Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.

Authors:  J W Knowles; G Esposito; L Mao; J R Hagaman; J E Fox; O Smithies; H A Rockman; N Maeda
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

3.  Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide.

Authors:  Karim Sabrane; Markus N Kruse; Larissa Fabritz; Bernd Zetsche; Danuta Mitko; Boris V Skryabin; Melanie Zwiener; Hideo A Baba; Masashi Yanagisawa; Michaela Kuhn
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

4.  A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.

Authors:  I Kishimoto; K Rossi; D L Garbers
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

5.  Evidence for a novel natriuretic peptide receptor that prefers brain natriuretic peptide over atrial natriuretic peptide.

Authors:  M F Goy; P M Oliver; K E Purdy; J W Knowles; J E Fox; P J Mohler; X Qian; O Smithies; N Maeda
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

Review 6.  Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases.

Authors:  Johanne Tremblay; Richard Desjardins; David Hum; Jolanta Gutkowska; Pavel Hamet
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

7.  Discovery of small molecule guanylyl cyclase A receptor positive allosteric modulators.

Authors:  S Jeson Sangaralingham; Kanupriya Whig; Satyamaheshwar Peddibhotla; R Jason Kirby; Hampton E Sessions; Patrick R Maloney; Paul M Hershberger; Heather Mose-Yates; Becky L Hood; Stefan Vasile; Shuchong Pan; Ye Zheng; Siobhan Malany; John C Burnett
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-28       Impact factor: 12.779

8.  A gene therapy approach for long-term normalization of blood pressure in hypertensive mice by ANP-secreting human skin grafts.

Authors:  Jean-Philippe Therrien; Soo Mi Kim; Atsushi Terunuma; Yan Qin; Christine L Tock; Wolfgang Pfützner; Manabu Ohyama; Jurgen Schnermann; Jonathan C Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-11       Impact factor: 11.205

9.  Disruption of Npr1 gene differentially regulates the juxtaglomerular and distal tubular renin levels in null mutant mice.

Authors:  Minolfa C Prieto; Subhankar Das; Naveen K Somanna; Lisa M Harrison-Bernard; L Gabriel Navar; Kailash N Pandey
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-09-20

10.  Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enteral NaCl load.

Authors:  John N Lorenz; Michelle Nieman; Jenine Sabo; L Philip Sanford; Jennifer A Hawkins; Noeet Elitsur; Lara R Gawenis; Lane L Clarke; Mitchell B Cohen
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.